Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Genentech pays $850M upfront for Regor's CDK inhibitors
Genentech is taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in patients failed by existing options.
Nick Paul Taylor
Sep 30, 2024 5:30am
Stryker strikes again, acquiring brain surgery devicemaker Nico
Sep 20, 2024 1:30pm
Danish CRO Scantox buys genotoxicity specialist Gentronix
Sep 10, 2024 7:44am
Psyence acquires fellow psilocybin biotech Clairvoyant
Sep 6, 2024 9:25am
J&J ordered to pay $1B over fallout from Auris robotics deal
Sep 5, 2024 4:10pm
Medera plans SPAC merger to advance cardiac gene therapies
Sep 5, 2024 10:50am